Paying users zone. Data is hidden behind: .
Get 1-month access to Vertex Pharmaceuticals Inc. for $15.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Vertex Pharmaceuticals Inc. pages available today for free:
Adjustments to Financial Statements
Adjustments to Total Assets
Vertex Pharmaceuticals Inc., adjusted total assets
US$ in thousands
Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16).
1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »
2 Deferred tax assets. See details »
Adjustments to Total Liabilities
Vertex Pharmaceuticals Inc., adjusted total liabilities
US$ in thousands
Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16).
1 Operating lease liability (before adoption of FASB Topic 842). See details »
2 Deferred tax liabilities. See details »
Adjustments to Stockholders’ Equity
Vertex Pharmaceuticals Inc., adjusted total Vertex shareholders’ equity
US$ in thousands
Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16).
1 Net deferred tax assets (liabilities). See details »
Adjustments to Capitalization Table
Vertex Pharmaceuticals Inc., adjusted capitalization table
US$ in thousands
Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16).
1 Operating lease liability (before adoption of FASB Topic 842). See details »
2 Current operating lease liabilities (included in Other current liabilities). See details »
3 Long-term operating lease liabilities. See details »
4 Net deferred tax assets (liabilities). See details »
Adjustments to Reported Income
Vertex Pharmaceuticals Inc., adjusted net income (loss) attributable to Vertex
US$ in thousands
Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-13), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-16).
1 Deferred income tax expense (benefit). See details »